Publications and media
July 1, 2020
Carag receives U.S. FDA IDE approval to conduct clinical study of first transcatheter septal occluder with bioresorbable, metal-free framework
Read more...
March 10, 2020
Carag first-ever septal occluder with bioresorbable, metal- free framework available to patients through new European registry
Read more...
September 18, 2017
CARAG Completes CE Marking for its Breakthrough Carag Bioresorbable Septal Occluder (CBSO)
Read more...
September 4, 2015
CARAG AG belegt den dritten Platz an der «SwissInnovation Challenge 2015»
Read more...
July 10, 2015
CARAG AG erreicht die letzte Runde der «SwissInnovation Challenge 2015» in Basel
Read more...
November 12, 2014
CARAG AG Wins the 2014 Zuger Innovation Prize
Read more...
May 14, 2014
CARAG AG announces successful First-In-Man implantation of the Carag Bioresorbable Septal Occluder – break- through in septal occlusion technology!
Read more...
